These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Isolation of tumoricidal human factors from lymphoid cells and enzymatic digestion of these factors into small fragments retaining tumoricidal effects. Cameron DJ J Surg Oncol; 1985 Aug; 29(4):249-55. PubMed ID: 3841173 [TBL] [Abstract][Full Text] [Related]
24. A lipophosphoprotein complex in hen plasma associated with yolk production. McINDOE WM Biochem J; 1959 May; 72(1):153-9. PubMed ID: 13651152 [No Abstract] [Full Text] [Related]
25. Stability of phospholipid binding in human serum lipoproteins. FLORSHEIM WH; MORTON ME J Appl Physiol; 1957 Mar; 10(2):301-4. PubMed ID: 13428665 [No Abstract] [Full Text] [Related]
26. Cytotoxic protein from human platelets. Golubeva TS; Paromov VM; Tuguz AR; Chertov OY; Kiselevsky MV FEBS Lett; 1997 Apr; 405(3):312-4. PubMed ID: 9108310 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of a factor from normal and abnormal human spleens for allogenic leukemia cells. Lozzio BB; Lozzio CB; Bamberger EG Am J Hematol; 1978; 4(1):57-65. PubMed ID: 655158 [TBL] [Abstract][Full Text] [Related]
28. Phospholipid antithromboplastin; assay in vitro and evaluation in vivo of purified fractions. SILVER MJ; TURNER DL; TOCANTINS LM Am J Physiol; 1957 Jul; 190(1):8-12. PubMed ID: 13458398 [No Abstract] [Full Text] [Related]
29. Molecular complexes in the isolation and characterization of plasma lipoproteins. CORNWELL DG; KRUGER FA J Lipid Res; 1961 Apr; 2():110-34. PubMed ID: 13695618 [No Abstract] [Full Text] [Related]
30. Reported effects of antireticulo-cytotoxic serum developed in Russia. McDONOUGH SJ Geriatrics; 1946; 1():295-8. PubMed ID: 20994262 [No Abstract] [Full Text] [Related]
31. [Phospholipids and its fractions]. Suzuki H Nihon Rinsho; 1999 Sep; 57 Suppl():45-8. PubMed ID: 10543045 [No Abstract] [Full Text] [Related]
32. New cytotoxic agents with tumour inhibitory activity. IV. Theoretical speculations. HENDRY JA; ROSE FL; WALPOLE AL Acta Unio Int Contra Cancrum; 1951; 7(3):490-4. PubMed ID: 14868581 [No Abstract] [Full Text] [Related]
33. Serological and chemical characterization of certain sera. I. Sera obtained from normal and cancer patients. HAKIM AA Clin Chim Acta; 1957 Dec; 2(6):560-6. PubMed ID: 13500591 [No Abstract] [Full Text] [Related]
35. Characterization of growth-inhibitory activities associated with an alpha-macroglobulin of mice. Koo PH Cancer Res; 1982 May; 42(5):1788-97. PubMed ID: 6175396 [TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of a novel cytotoxic protein from transformed fibroblasts. Zucker S; DiMassimo BI; Lysik RM; Lyubsky S Cancer Res; 1993 Mar; 53(5):1195-203. PubMed ID: 8439964 [TBL] [Abstract][Full Text] [Related]
37. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2. Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359 [TBL] [Abstract][Full Text] [Related]
38. The structure of the lower-density lipoproteins of human plasma: newer concepts derived from studies with the analytical ultracentrifuge. Fisher WR Ann Clin Lab Sci (1971); 1972; 2(3):198-208. PubMed ID: 4343277 [No Abstract] [Full Text] [Related]
39. Natural cytotoxins in human plasma: isolation and characterization of phospholipids associated with cytotoxic lipoproteins. Prezioso JA; Koo PH Mol Toxicol; 1987; 1(2-3):191-208. PubMed ID: 3449757 [TBL] [Abstract][Full Text] [Related]